Nevertheless, pathogenic alterations in α-synuclein occur in Parkinson’s disease, which furthers the disease’s advancement (Stefanis, 2012; Xu and Pu, 2016; Calabresi et al., 2023). This evidence concerns the gene SNCA and Parkinson disease.